Unitree, the world's largest humanoid robot producer by shipment volume, has applied to list on Shanghai's tech-heavy Star market. The IPO is expected in the second half of 2025. Founded in 2016 by engineer Wang Xingxing, Unitree gained fame for its robots' performances at state galas. In the first nine months of 2025, 74% of humanoid revenue came from research and education orders, 13% from consumers, and 9% from industrial demand. Gross margin stood at 59.8%. The company hopes to raise Rmb2bn, with half earmarked for intelligent robotics models development. However, analysts question the sustainability of its valuation, noting that most current orders are from universities and government-backed training centers rather than large-scale industrial applications. The company's ability to shift from a hardware success story to a solution provider for industrial labor replacement remains unproven. Unitree's listing will test investor appetite for humanoid robotics amid high valuation expectations.
Unitree, a private humanoid robot maker, has applied for a public listing on Shanghai's Star market, offering investors their first chance to evaluate the humanoid robot industry on public markets.
Unchanged: The core technical capabilities and product lineup of Unitree remain unchanged; the company continues to produce humanoid and quadruped robots. The fundamental question of whether humanoid robots can achieve widespread industrial adoption remains unanswered.
The article conveys cautious optimism. It highlights Unitree's impressive technical achievements and market leadership but questions the sustainability of its valuation given limited industrial use cases.
IPO validates humanoid robotics as a serious investment category, potentially driving more funding and innovation.
Focus on intelligent robotics models highlights integration of AI into physical systems.
Unitree's in-house component manufacturing demonstrates hardware excellence and cost optimization.
High valuation and unproven industrial use cases create both opportunity and risk for business models.
Successful IPO could pave the way for other robotics startups to go public and access capital.
Market leader in humanoid robotics but faces valuation and use case challenges.
Founder and engineer recognized by Xi Jinping; visionary behind Unitree.
Competitor with lower shipments and similar valuation; may be overshadowed.
Competitor shipping >5,000 robots; unclear comparative performance.
Analyst providing market commentary on robotics.
Unitree's IPO is a litmus test for the humanoid robotics industry's commercial viability. While the company leads in shipments and has impressive technology, the majority of current revenue comes from research and entertainment rather than industrial applications. If the IPO attracts strong investor demand, it could fuel a wave of investment and competition in the sector. However, failure to convince markets of scalable use cases could temper enthusiasm for other robotics startups. The outcome will signal whether humanoid robots are seen as a near-term industrial reality or a speculative long-term bet.
Opportunity to invest in humanoid robotics leader with high growth, but valuations are premium and industrial use cases unproven.
Successful IPO could attract more capital and talent to humanoid robotics, accelerating innovation.
Unitree's IPO and valuation benchmark may pressure competitors to demonstrate commercial viability.
IPO aligns with China's strategic push for advanced manufacturing and robotics leadership.
IPO may lead to more funding for R&D, but real-world industrial applications remain limited.
IPO boosts China's robotics leadership and aligns with government strategic goals.
Unitree was on US defense list; US companies may face competitive pressure if humanoids become viable.
Global investors have opportunity but face uncertainty in industrial adoption and geopolitical risks.
Robotics not directly cyber-oriented.
Not data-intensive system.
No major incidents.
Need to pivot from research/education to industrial use cases.
Relies on existing manufacturing infrastructure.
US defense list inclusion and China tech competition create geopolitical tensions.
IPO regulations and potential export controls on robotics technology.
In-house components reduce but some dependencies remain.
If humanoids replace labor, significant displacement potential.
AI-driven robots in industrial settings pose liability concerns.
Included Unitree on military company list, creating potential US market barriers.
US agricultural robotmaker providing external perspective on Unitree's industrial viability.
Analyst firm providing valuation and growth expectations.